Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Sarcoma
Study Phase
Phase 3
Study Completion Date
2021-03-31
NCT02306161Uploaded 08-31-2024
Access via NCI by Request
PDS UID: nci-data-553
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Files: NCT02306161-D1
Data DictionaryNCT02306161-D1-Data-Dictionary.pdf
DATANCT02306161-D1-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D2
Data DictionaryNCT02306161-D2-Data-Dictionary.pdf
DATANCT02306161-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D3
Data DictionaryNCT02306161-D3-Data-Dictionary.pdf
DATANCT02306161-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D4
Data DictionaryNCT02306161-D4-Data-Dictionary.pdf
DATANCT02306161-D4-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D5
Data DictionaryNCT02306161-D5-Data-Dictionary.pdf
DATANCT02306161-D5-Dataset.csv
OTHERREADME.pdf